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The  mechanism by  which  cytotoxic T  lymphocytes (CTL) j  recognize and 
subsequently destroy target cells remains obscure. This process occurs in three 
discrete steps:  (a)  recognition and binding  of the CTL  to  the target cell,  (b) 
programming for  lysis,  and  (c)  target  cell  destruction.  One  requirement for 
proper  recognition by CTL  is  the simultaneous expression on  the target cell 
plasma membrane of a specific foreign antigen and a particular histocompatibility 
molecule. At the CTL level, not only is the T  cell receptor for antigen necessary 
for target cell recognition (1,  2) but a  number of other molecules have been 
implicated  in  CTL-induced  lysis.  These  include  T3,  which  is  noncovalently 
associated with  the T  cell antigen receptor (3,  4);  Lyt-2 (5,  6) and  L3T4  (7), 
which may confer specificity for a particular class of histocompatibility molecule; 
and the leukocyte function-associated antigens (8).  In each of these cases the 
binding of antibodies specific for these proteins to the CTL cell surface results 
in the inhibition of CTL-mediated lysis.  However, since all of these molecules 
are present on naive, noncytolytic CTL precursors, activational processes must 
occur  after  a  primary  encounter  with  antigen  which  allow  the  subsequent 
expression of cytolytic capability by CTL in an antigen-specific manner. 
Recently (9, 10), we have described activation antigens that are associated with 
CTL (termed CT determinants). Monoclonal antibodies (mAb) specific for these 
antigens inhibit the function of CTL expressing high levels of CT antigen on 
their surface. Biochemical analyses revealed that the CT determinants are present 
on the T200 molecules of murine CTL and on two other unidentified cell surface 
proteins.  Although forms of T200  are found on all T  cells and hematopoietic 
cells except cells of erythroid lineage (11),  the CT antigens are expressed only 
on the T200 glycoprotein of activated CTL. T200 has been previously implicated 
in  natural  killer  (NK)  cell-mediated  lysis  (12,  13)  but  its  role  in  the  lytic 
mechanism of CTL remains controversial. The Ly-5 alloantigenic determinants 
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are present on the T200 molecule (14,  15), and anti-Ly-5 sera has been shown 
in  some  cases  (5,  16),  but  not  others  (17,  18),  to  inhibit  CTL-mediated  lysis. 
mAb specific for T200 have generally been unable to inhibit CTL function (9, 
19) but this result may be due to the epitope specificity of the individual mAb 
(20). Although involvement of T200 in other immunological mechanisms includ- 
ing  B  cell differentiation  has  been  suggested  (21),  the precise function  of the 
T200 glycoprotein remains undefined.  A  recent report (22) indicated that the 
T200/Ly-5 molecule may have an autoproteolytic activity. 
These findings led us to investigate the maturational alterations of CTL T200 
during activation that lead to CT antigen expression. Our previous results (10) 
indicated that,  during in vitro activation of CTL, progressive modifications of 
the T200 glycoprotein occur that result in an increase in the apparent molecular 
weight and the number of different T200 molecules present on the cell surface. 
During this process the CT determinants appear early after activation at relatively 
low levels and gradually increase in concentration during prolonged culture in 
the presence of soluble factors. This increase in expression occurs concomitant 
with the apparent molecular weight changes observed in the T200 glycoproteins. 
We now report that the CT determinants are carbohydrate in nature and that 
their expression appears to be regulated by interleukin  2  (IL-2).  Furthermore, 
the character of the carbohydrate present on the cell surface of CTL appears to 
be  dramatically  different  than  that  of T  cells  of the  T  helper  (Th)  lineage, 
particularly  in  regard  to  O-linked  glycans.  Thus,  our results  demonstrate  the 
presence of cell-type-specific oligosaccharides  whose expression  is hormonally 
regulated and functional in nature. 
Materials and Methods 
Mice.  C57BL/6J (B6, H-2  b) and DBA/2 (H-2  a) were obtained from the vivarium at 
Scripps Clinic and Research Foundation. 
Monoclonal Antibodies.  mAb used for these studies were: 13-4, anti-Thy-l.2 (23); anti- 
Lyt-2 (24); and I3/2.3, anti-T200 (25; generously provided by Dr. Ian Trowbridge, The 
Salk Institute). The production and characterization of the CT mAb have been previously 
described (9,  10). CTI and CT2 have been typed as IgM, ~ light chain type. 
Cell Lines.  The CTL clones used here have been previously described (10). CTL clone 
H7  was  derived from a  C57BL/6J  mouse and  is  specific for a  BALB minor antigen 
recognized in  conjunction with  I-I-2K  b,  The noncytolytic Th clone BB5,  which is  Mls 
reactive, was kindly provided by Dr. Andrew Glasebrook, Eli Lilly Research Co., LaJolla, 
CA. Other cell lines used were P815 (H-2  d, mastocytoma) and EL4 (H-2  b, thymoma). 
Mixed Lymphocyte Cultures (MLC).  Primary in vitro cultures were established by cocul- 
turing  5  x  10  6  spleen  cells  with  5  x  106  irradiated (2,000  rad  from a  ~37Cs source) 
stimulator spleen cells in 2 ml of RPMI  1640 medium with 5% fetal calf serum with or 
without the addition of  purified recombinant human IL-2 (rIL-2) (Cetus Corp., Emeryville, 
CA) in  24-well  tissue culture plates (Costar,  Cambridge,  MA).  The IL-2 concentration 
was  equivalent  to  the  level  of IL-2  in  5%  supernatant  from  concanavalin  (Con  A)- 
stimulated rat spleen cells (66 U/ml). Long-term cultures were propagated by culturing 5 
X  10 5 tO  1  X  10 6 cells from primary MLC with 5 x  10 6 irradiated stimulator cells in 2 ml 
cultures and restimulating every 7 d. 
Immunofluorescent  Staining.  Viable cells were obtained by passage of cell populations 
over Ficoll-Isopaque (26). After washing, the cells were resuspended in phosphate-buffered 
saline (PBS)-0.1% bovine serum albumin (BSA)-0.1% NaN3 (containing I mM CaCt2 and 
MgSO4) at a concentration of 1 ×  107/ml.  1 ×  106 cells were incubated with  100 #1 of a 
1:100 dilution of ascites fluid containing the primary mAb at 4 °C followed by incubation LEFRANCOIS ET  AL.  1277 
with  an appropriate  dilution  of the secondary fluorescein-conjugated antibody that was 
either  an  affinity-purified  F(ab')2  rabbit  anti-mouse  Ig reagent  (Cappel  Laboratories, 
Cochranville,  PA) or a  goat anti-rat  Ig reagent  (Cappel  Laboratories).  The  cells  were 
then washed three times and resuspended at 1 X 106 cells/ml for cytofluorimetric analysis. 
For staining with lectins, fluorescein isothiocyanate-labeled lectins were used (E-Y Labo- 
ratories, San Mateo, CA). Relative fluorescent intensities of individual cells were measured 
using the FACS IV (Becton Dickinson lmmunocytometry Systems, Mountain View, CA) 
equipped with a  5 W  argon laser.  Forward angle light scatter was used to exclude dead 
and  aggregated  cells.  The  results  are  presented  as  fluorescence  histograms  with  the 
relative number of ceils on a linear scale plotted vs. the relative fluorescence intensity on 
a logarithmic scale, both in arbitrary units. 
Cell Surface Periodate Treatment.  Viable CTL clone H7 cells were fixed with 3% (wt/ 
vo]) paraformaldehyde in PBS and subsequently washed in PBS-0.1% glycine. The fixed 
cells were then incubated for 2 h at 37°C in 0.05 M sodium acetate buffer, pH 5.5, with 
or without the addition of 0.08 M  sodium m-periodate. The cells were then washed and 
stained as described above. 
Radioimmunoprecipitation.  Cell surface proteins were radioiodinated by the lactoper- 
oxidase  method  (27).  The  cells  were  first  centrifuged  over  Ficoll-Isopaque to remove 
residual  stimulator cells and dead cells and,  in some cases, again centrifuged over 30% 
Percoll to further remove debris (28). For iodination, cells were suspended at 1 ×  107/ml 
in PBS/5 mM glucose. Na~25I (1  mCi/107 cells),  lactoperoxidase (20 #g/ml), and glucose 
oxidase (0.!  IU/ml) were added in succession and the mixture was incubated for 20 min 
at room temperature.  For metabolic labeling, CTL clones (1 X 107/ml) were incubated at 
37 °C in methionine-free RPMI for 30 rain before addition of [35S]metbionine (250 #Ci/ 
ml). For pulse labeling, the cells were harvested after 5 rain, an aliquot taken and placed 
on ice, and the remainder of the cells incubated at 37°C in medium containing 10 mM 
methionine for the indicated times. For inhibition of N-linked glycosylation, the cells were 
incubated at 37°C in medium containing 5 ~g/ml tunicamycin for 2 h  before depletion 
of methionine  for  30  rain  and  the  addition  of [~SS]methionine  (250  #Ci/ml)  for  an 
additional 2 h incubation. After washing, the cells were resuspended in RIPA buffer (10 
mM  Tris,  pH  7.4,  0.15  M  NaCl,  1%  Triton  X-100,  1%  sodium  deoxycholate,  0.1% 
sodium dodecyl sulfate [SDS], 1 mM phenylmethylsulfonyl fluoride,  10 mg/ml BSA, and 
100  Kallikrein  units  of aprotinin  per  milliliter)  and  incubated  on ice for 30  min.  The 
lysates were centrifuged at 50,000 g for 20 rain and precleared twice with fixed Staphylo- 
coccus aureus cells (Pansorbin; Calbiochem-Behring Corp., La Jolla, CA). Aliquots of the 
supernatant were incubated with CT1 or I3/2.3 or, as a control, bovine gamma globulin 
coupled directly to Sepharose 4B. After incubation at 4°C the immune complexes were 
washed extensively with RIPA buffer. For removal of high mannose oligosaccharides the 
washed precipitates were boiled in 50 mM Tris-HCI, pH 6.8, and  1%  SDS, followed by 
the addition of 0.15 M sodium citrate, pH 5.5, with or without the addition of endogly- 
cosidase H  (endo H) (Miles Laboratories, Inc., Naperville, IL) at a concentration of 2/~g/ 
ml. Digestion was carried out for 16 h at 37 ° C. The precipitates were disrupted in sample 
buffer  (40%  glycerol,  4%  SDS  with  5%  2-mercaptoethanol)  and  analyzed  by  SDS/ 
polyacrylamide gel electrophoresis  (SDS-PAGE) (29),  using as acrylamide  stock a  30% 
(wt/vol) acrylamide, 0.17% bis-acrylamide solution, followed by fluorography (30). After 
drying, the gels were subjected to autoradiography at -70°C using Kodak XAR-5 x-ray 
film and Dupont Cronex intensifier screens. 
Limited Proteolysis  and Peptide Mapping.  Partial proteolysis of proteins was carried out 
with S.  aureus V8 protease  (Miles  Laboratories,  Inc.) by the method of Cleveland et al. 
(31).  Immunoprecipitated  proteins were separated on a  7.5%  acrylamide gel and,  after 
drying of the gel and autoradiography, the labeled proteins were excised and rehydrated 
in  125 mM Tris-HCI, pH 6.8,  1 mM EDTA, 0.1%  SDS,  1 mM 2-mercaptoethanol, and 
30% glycerol. The rehydrated gel slices were placed in wells of a  15% polyacrylamide gel 
and overlaid with buffer containing S.  aureus V8 protease (2 #g/slice). The samples were 
run into the stacking gel, electrophoresis was stopped, and, after 30 min, electrophoresis 
was started.  The gels were processed as described above. 1278  CYTOTOXIC  T  LYMPHOCYTE-SPECIFIC  CARBOHYDRATE  ANTIGENS 
Results 
Proteins Precipitated by CT mAb Are Not Related at the Peptide Level.  Our initial 
characterization of the two CT antigen-reactive mAb, CT1  and CT2, indicate 
that  these mAb bind  to  nonidentical but overlapping epitopes (10).  CT2  also 
differs from CT1  in  that  it  functions poorly in  immunoprecipitation whereas 
CT1  is very efficient. Therefore, we used CT1  in all of the biochemical charac- 
terizations  described here.  We  have previously shown  (9)  that  the  CT1  mAb 
immunoprecipitates from  1251 surface-labeled CTL  clones five major  proteins 
with apparent molecular weights (Mr) of 240,000  (240  K),  220,  200,  140, and 
85  K.  A  minor  protein  of M,-  190  K  is  also  sometimes  observed  (Fig.  1A). 
Sequential immunoprecipitation revealed that the proteins of Mr 240,  220, and 
200 K bore determinants recognized by a T200-specific mAb, while the 140 and 
85  K proteins did not (9).  Western blot analysis indicated that all five proteins 
contained antigenic determinants recognized by CT mAb. When the CTL clone, 
H7, was labeled with [35S]methionine and immunoprecipitation was carried out 
with the CT1  mAb, three high molecular weight proteins (Mr 240, 220, and 200 
K)  were precipitated,  as  well as  a  protein  of Mr  155  K  (gp155)  that  was  not 
FIGURE  1.  Limited proteolysis of CT reactive proteins. CTL clone H7 was surface labeled 
with 1251 or metabolically labeled with [35S]methionine for 2 h  as described in  Materials and 
Methods. Immune precipitation was carried out with mAb CTI  coupled directly to Sepharose 
4B. The precipitated proteins were separated on a  7.5% SDS-polyacrylamide gel (A), excised 
from  the gel,  and digested  with  2  #g  per  lane of S.  aureus  V8  protease.  (1-5)  125I-labeled 
proteins: (1) Mr  240  K;  (2)  220  K;  (3)  200  K;  (4)  140  K;  (5)  85  K.  (6-9)  [35S]methionine- 
labeled proteins: (6) 240 K; (7) 220 K; (8) 200 K; (9) 155 K. LEFRANCOIS ET AL.  1279 
observed in precipitates from surface-labeled cells (Fig.  1 A). In some cases, after 
prolonged exposure we observed the Mr 85 K protein but not the 140 K protein 
in precipitates from [S5S]methionine-labeled cell extracts. To determine if the 
CT-reactive proteins were closely related at the protein level and thus perhaps 
contained a crossreactive determinant, we obtained peptide maps. Both the lz5I 
surface-labeled (Fig.  1 A) and the [35S]-labeled  proteins were digested using S. 
aureus V8 protease and the resulting peptides separated by SDS-PAGE. The 1251- 
labeled T200 proteins of Mr 240, 220, and 200 K gave virtually identical maps, 
with a  number of low molecular weight peptides evident (Fig.  1 B,  1-5).  This 
agrees well with previously published peptide maps of the T200  glycoprotein 
(33). Digestion of the 125I-labeled, Mr 140 K protein (Fig.  1 B, 4) resulted in the 
appearance of peptides that comigrated with peptides of the T200 proteins but 
also in the appearance of new peptides. Thus,  it was possible that this protein 
was related to the T200 glycoprotein. However, digestion of the ~25I-labeled Mr 
85 K protein (Fig.  1 B, 5) yielded a single large peptide of Mr ~35 K, suggesting 
that  this  protein  was  not  related  to  T200.  In  addition,  although  the  [35S]- 
methionine-labeled T200 proteins gave similar peptide maps, gp155 was virtually 
undigested under identical conditions (Fig.  1 B, 6-9).  These results suggest that 
the antigenic determinants recognized by the CT mAb may not be protein in 
nature,  since  proteins  unrelated  at  the  peptide  level  are  CT  reactive.  It  is 
interesting to note that unique high molecular weight peptides are also observed 
upon  digestion  of the  35S-labeled,  Mr  240,  220,  and  200  K  proteins.  These 
differences could be accounted for by heterogeneous glycosylation, proteolytic 
processing, or primary amino acid differences. 
Carbohydrate Is Required for the Expression of CT Determinants.  Because some 
of the proteins reactive with the CT mAb were not related at the peptide level, 
it was possible that the CT antigens were the result of other modifications of the 
CT  + proteins, such as the addition of oligosaccharides during protein processing. 
This possibility was examined by treating the cell surface of CTL clone H7 with 
sodium m-periodate, which preferentially oxidizes carbohydrate beginning with 
sialic acid residues (34), and then determining the level of CT mAb binding by 
fluorescence flow cytometry (Fig. 2). Periodate treatment of the cell surface did 
not significantly affect the binding of the anti-T200  mAb,  indicating that the 
T200  protein  was  not destroyed by periodate treatment (Fig.  2,  A  vs.  B).  In 
contrast,  while the CT  mAb bound at  very high  levels to  the control-treated 
CTL clone (Fig. 2 A), >90 % of their reactivity was lost after cell surface periodate 
treatment (Fig. 2 B), suggesting that carbohydrate was necessary for CT antigen 
expression. 
Further evidence for the necessity of carbohydrate in CT determinant expres- 
sion  was obtained by performing immunoprecipitations from [SSS]methionine- 
labeled, tunicamycin-treated CTL clone H7.  Clone H7  was pretreated for 2  h 
with tunicamycin, incubated in methionine-free medium for 30  min, and incu- 
bated for a  further 2 h  in medium containing [~5S]methionine with or without 
the addition of tunicamycin. Anti-T200 mAb precipitated the three high molec- 
ular weight proteins (mr 240,  220,  and 200  K) from lysates of untreated cells 
(Fig. 3, lane 1) while three proteins of Mr 165, 155, and 150 K were precipitated 
by anti-T200 from lysates of tunicamycin-treated cells (Fig.  3, lane 2).  As seen 1280  CYTOTOXIC  T  LYMPHOCYTE-SPECIFIC  CARBOHYDRATE  ANTIGENS 
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FIGURE 2.  Periodate treatment of the cell surface abrogates CT mAb binding. CTL clone 
H7 was fixed in 3% (wt/vol) paraformaldehyde and incubated at 37°C for 2 h in buffer (0.05 
M sodium acetate, pH 5.5) without (A) or with (B) the addition of 0.08 M sodium m-periodate. 
The cells were then processed for fluorescence analysis as described in Materials and Methods, 
using 13/2.3 (anti-T200), CT1, or CT2. Dotted lines indicate staining of H7 cells with the 
fluorescein isothiocyanate-labeled second antibody alone. The cells  were then analyzed by 
fluorescence flow cytometry. 
FIGURE  3.  Blocking of N-linked glycosylation by tunicamycin prevents CT1 binding to T200 
proteins. CTL clone H7 was grown in the presence (2, 4) or absence (I, 3, 5) of tunicamycin 
and labeled with [35S]methionine. Immune precipitation was then carried out with I3/2.3 (anti- 
T200) (1, 2), CT1 (3,  4), or bovine gamma globulin (5), coupled to Sepbarose 4B, and analyzed 
on a 7.5% SDS-polyacrylamide gel. 
in  Fig.  1,  CT1  precipitated  proteins  of Mr  240,  220,  200,  and  155  K  from 
untreated  cells  (Fig.  3,  lane  3).  An  additional  protein  of Mr  250  K  was  also 
precipitated  and  is variably present  in CT1  precipitates  (Fig.  3,  lane 3;  see  Fig. LEFRANCOIS ET AL.  1281 
4).  When precipitates were obtained with CT1  from tunicamycin-treated cells, 
only a single protein of Mr 150 K was observed and none of the T200 precursor 
molecules  were  apparent.  Although  the  T200  precursor  proteins  could  be 
obscured by the Mr  150  K protein, pulse chase experiments indicated that this 
was not the case (see below). Therefore, inhibition of N-linked glycosylation of 
the T200 proteins by tunicamycin results in the loss of CT determinants. Because 
gp155 still  bears CT determinants after blocking of N-linked glycosylation, the 
CT antigens may be dependent on the addition of O-linked oligosaccharides to 
glycoproteins. Indeed, when the tunicamycin experiments were repeated using 
clone H7  grown in  [3H]glucosamine, only the gpl50  was labeled and not the 
T200  precursors (data not shown). These results suggest that gp155  is  trans- 
ported  normally  from  the  rough  endoplasmic  reticulum  through  the  Golgi 
complex despite the lack of N-linked glycosylation, and that T200 is blocked in 
transport as a result of the loss of N-linked glycans. Examples of both of these 
situations have been previously observed for a number of proteins (35). 
Synthesis of  gp l55 Suggests CT Determinants Require O-linked Oligosaccharides  for 
Expression.  Since  gp155  retains  the  carbohydrate antigens  required  for  CT 
mAb binding regardless of the addition of N-linked glycosylation, the protein 
must still  be transported within the cell to obtain the glycans necessary for CT 
antigen expression. We asked whether gp155 was a secreted protein, and, if so, 
whether it  was secreted in  the presence of tunicamycin. Culture supernatants 
from  H7  cells  labeled  with  [35S]methionine  in  the  presence  or  absence  of 
tunicamycin were clarified by centrifugation at 50,000 g and immune precipita- 
tion  was  performed.  As  immunosorbents,  CT1,  anti-T200,  and  an  N-acetyl 
galactosamine (GalNAc)-binding  ]ectin  from  Vicia villosa  (VV)  were  used.  If 
gp155 receives carbohydrate modifications after blocking of N-linked glycosyla- 
tion, they may be expected to be of the O-linked type. Since GalNAc has been 
shown to occur primarily on O-linked glycans, VV could detect these moieties 
(36,  37).  For comparison, a  CT1  immunoprecipitate from SsS-labeled H7  cell 
extracts is shown (Fig.  4,  lanes  1,  2).  Lanes 3  and 4  are precipitates obtained 
using a  control  immunosorbent.  Precipitation by CT1  of culture supernatant 
from untreated H7 cells revealed a major protein species of Mr 150 K, indicating 
that  gp155  is  secreted  (lane  5).  Precipitation  by  CT1  from  supernatants  of 
tunicamycin-treated cells yielded a single protein of M,  145  K  (Fig. 4,  lane 6), 
showing that  the gp155  precursor is  still  secreted after blocking of N-linked 
glycosylation. The secreted proteins, in the absence or presence of tunicamycin, 
are of a slightly lower molecular weight (150 K,  145 K) than that obtained from 
cell lysates from tunicamycin-treated cells (155K,  150 K), perhaps due to further 
processing during secretion. When VV was used for precipitation from super- 
natants of untreated cells, a  number of proteins were obtained :including one 
comigrating with gp 150 and a protein of Mr 105 K, while VV precipitates from 
tunicamycin-treated cells contained a single major protein of Mr  145  K.  Immu- 
noprecipitation by anti-T200 from H7 supernatants (Fig. 4, lane 9) or by CT1 
from supernatants from a Th cell clone grown under identical conditions (lane 
10)  did  not  result  in  the  isolation  of any protein  species.  Thus,  gp155  is  a 
secretory protein that is transported in the absence of N-linked glycosylation and 
probably contains O-linked glycans that are involved in CT determinant expres- 1282  CYTOTOXIC  1"  LYMPHOCYTE-SPECIFIC  CARBOHYDRATE  ANTIGENS 
FIGURE 4.  Reactivity of secreted proteins with CT1.  CTL  clone H7  (I-9)  or noncytolytic 
Th clone BB5 (I0) were incubated in medium containing [SSS]methionine (250 uCi/rnl) for 4 
b. Cell  lysates (1-4) or supernatants (5-10) were subjected to immunoprecipitation by CT1 
(1,  2,  5, 6,  10), Vicia villosa  (7,  8),  13/2.3  (anti-T200) (9) or bovine gamma globulin (3,  4). 
Cells were incubated in the presence (2, 4, 6, 8) or absence (1, 3, 5,  7, 9, 10) of tunicamycin. 
sion.  The  characteristics  of  gp155  are  very  similar  to  a  recently  described 
sulphated  glycoprotein  (38,  39),  called  entactin,  which  is  associated  with  the 
extracellular matrix and basement membrane.  In fact, the gp155 described here 
is  also  heavily  sulphated  (data  not  shown).  The  significance  of this  secretory 
protein for CTL function in vivo is an intriguing issue to be addressed. 
CT Carbohydrate  Antigens Are Acquired Late in T200 Biosynthesis.  Our evidence 
thus far suggests that CT determinants are the result of the addition of O-linked 
glycans to T200 and at least three other glycoproteins. To determine the point 
in protein biogenesis at which the CT determinants were acquired, we performed 
pulse  chase  experiments  using  CTL  clones  (Fig.  5).  The  H7  CTL  clone  was 
pulsed for 5 min with [35S]methionine and incubated for the indicated times in 
medium  containing  an  excess  of unlabeled  methionine.  Precipitates  obtained 
with CT1 or anti-T200 were treated with endo H, which removes high mannose 
type oligosaccharides (40). Since resistance to endo H  is acquired after synthesis 
in rough endoplasmic reticulum during transit to the Golgi complex, this exper- 
iment should give an indication of the point at which CT antigens are acquired. 
Precipitation  with anti-T200  after 5  min  of labeling gave three proteins of Mr 
187,  180, and  173  K (Fig.  5A, lane  I). After treatment  of this precipitate with 
endo H, three proteins of Mr 165,  157, and  150 K were seen, indicating that all 
of the T200 oligosaccharides at this time are sensitive to removal with endo H 
(Fig.  5A,  lane  2).  After  10  min  of chase,  -20%  of the  oligosaccharides  were 
resistant to cleavage by endo H, while 50% were resistant to removal at 20 rain Q
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of chase. At later times (40 min,  70 rain) a minor decrease (~5 K) in molecular 
weight of the high  molecular weight proteins was observed after endo H  treat° 
ment.  This  decrease  was  also  observed  when  the  ~25I surface-labeled  T200 
proteins were treated with endo H  (data not shown), indicating that one to two 
oligosaccharides  in  the  mature  form  of  the  protein  contain  bigh  mannose 
carbohydrate moieties~ 
The same lysates used for anti-T200  precipitation  were subjected to precipi- 
tation with CT1. After 5 min of labeling (Fig. 5B, time 0) only a minor amount 
of gp155  was precipitated  with  CT1  and  its oligosaccharides were resistant  to 
removal with endo H.  None of the lower molecular weight precursor forms of 
T200 were precipitated by CTI (compare A and B, time 0, Fig. 5). After 10 min 
of chase,  minor amounts of the  mature  high  molecular weight forms of T200 
glycoproteins and none of the earlier precursors were precipitated. The intensity 
of gp155 was significantly increased at this point and a protein of Mr 250 K was 
also precipitated  (as mentioned,  this protein  is of unknown identity and is only 
occasionally observed in  precipitates  from  surface-labeled cells).  After  20,  40, 
and  70  min  of chase,  all  of the  high  molecular  weight  forms  of T200  were 
precipitated  by CT1  and, again,  none of the less mature forms were observed. 
Thus,  the  CT  determinants  appear  to  be  acquired  relatively  late  in  T200 
biogenesis, concomitant with or after the acquisition of endo H-resistant oligo- 
saccharides. This result agrees with our contention that O-linked glycans consti- 
tute  the  CT  antigen,  since  the  terminal  stages  of O-linked  glycosylation  are 
thought to occur in the Golgi complex, at which time most N-linked oligosaccha- 
rides are resistant to removal by endo H  (41). 
Differences in Cell Surface Carbohydrate Between Cytotoxic and Th Cells.  Since 
the CT antigens require carbohydrate for expression and the CT mAb bind only 
to  CTL  and  not  to  Th  phenotype  T  cells,  we  wished  to  determine  if more 
generalized differences in cell surface oligosaccharides are evident in comparisons 
between CTL  and  Th.  To address  this  question,  saturating  concentrations  of 
fluorescein-conjugated lectins were bound to the surface of CTL or Th  clones 
and  the degree of binding  was measured  by fluorescence flow cytometry (Fig. 
6). The lectins used were VV and Helix pomatia (HP), both of which are specific 
for  D-GalNAc,  and  Con  A,  which  is  specific for alpha-D-glucose  and  alpha-D- 
mannose. As we have previously observed, CTL clones (in this case H7) expressed 
very high  levels of CT antigens (Fig.  6A).  Significant  levels of T200 were also 
detected (it should be noted that the concentration  of T200 cannot be directly 
compared  with  CT  since a  different  second-step reagent  was used).  Similar  to 
CT binding,  VV, HP, and Con A bound at high levels on CTL clone H7 (Fig. 
6B)  (this  binding  was  totally  inhibited  by the  appropriate  monosaccharides). 
However, the noncytolytic Th clone, BB5, expressed extremely low levels of CT 
antigen (Fig. 6 C). Interestingly, VV and HP binding was also dramatically lower 
(~10-20-fold  lower)  to  Th  clone  BB5  than  to  H7  (Fig.  6D).  However,  BB5 
bound Con A  at an  equivalent level to that  observed with H7.  Since CT mAb 
do not react significantly with BB5, but VV and HP do bind at moderate levels, 
it is clear that  the CT mAb have much  stricter requirements  for binding  than 
the latter two lectins. (This has been confirmed by immunoprecipitation as well; 
data  not  shown).  Furthermore,  since  GalNAc  is  found  primarily  on  O-linked LEFRANCOIS ET  AL.  1285 
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FIGURE 6.  Analysis  of CT mAb and lectin binding to CTL and Th. CT1, CT2, I3/2.3 (anti- 
T200), or lectins from VV, HP, or Con A were reacted with CTL clone H7 (A, B) or Tb 
clone BB5 (C, D) followed by reaction with a fluorescein isothiocyanate-labeled secondary 
antibody in the case of the mAb (lectins were directly fluoresceinated). The binding was then 
measured by fluorescence flow cytometry. Dotted fines indicate staining with the fluorescein 
isothiocyanate-labeled secondary antibody. 
glycans, the majority of carbohydrate differences between CTL and Th appear 
to be O-linked in character. Using a large panel of lectins, we have now confirmed 
that the major differences between CTL and Th are associated with increases in 
GalNAc-containing oligosaccharides (unpublished results). 
IL-2 Induces the Expression  of CT Determinants.  The dichotomy in CT antigen 
expression  observed  between  CTL  and  Th  suggested  an  inherent  metabolic 
difference affecting glycosylation between the two cell types. We had previously 
observed  (10)  that,  during  continuous  culture  of cytolytic mixed  lymphocyte 
cultures  (MLC),  a  marked  shift  from  low  to  high  expression  of CT  antigen 
occurred only if supernatants from Con A-induced rat spleen cells were added 
to the culture. These supernatants contain high levels of IL-2 and a  number of 
other soluble factors.  With  the availability of highly purified recombinant IL-2 
(rlL-2), we have now been able to perform these experiments in a more defined 
system. MLC were initiated in the presence or absence of rlL-2 and analyzed for 
CT antigen expression at various times. Primary MLC cells (and cells from long- 
term MLC cultured without rlL-2) expressed relatively low but significant levels 
of CT antigen (Fig.  7A).  The level of VV,  HP, and Con A  binding to primary 
MLC cells was also determined. Low to moderate levels of VV- and HP-reactive 
determinants  were  present,  while  Con  A  bound  at  a  high  level.  At  3  wk  of 
culture, the CT determinant density had increased dramatically and was distrib- 1286  CYTOTOXIC  T  LYMPHOCYTE-SPECIFIC  CARBOHYDRATE  ANTIGENS 
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FICUl~E 7.  IL-2 induces marked changes in CT antigen expression and GalNAc expression 
in MLC. C57BL/6 spleen cells were cocultured with irradiated DBA/2 spleen cells in medium 
without (A, B) or with (C-F) the addition of purified rIL-2. Cultures were restimulated every 
7 d for 2 wk (A, B), 3 wk (C, D), or 5 wk (E, F). Viable cells were stained and analyzed as in 
Fig. 6. The binding of VV and HP was >95% inhibited by soluble GalNAc (0.1 M) and Con 
A binding was >95% inhibited by a-methylmannoside (0.1 M). 
uted between two major cell populations (Fig. 7 C). (It should be noted that these 
cells were >95% of the CTL phenotype Thy-1 +, T200 +, Lyt-2  +, L3T4-). A very 
interesting result was obtained when lectin binding to these cells was analyzed. 
While Con A  binding levels remained high, a significant increase in VV and HP 
binding  was  noted  as  compared  with  primary  MLC  cells.  Furthermore,  VV 
binding was bimodally distributed in a  pattern similar to CT mAb binding (Fig. 
7D). After two additional restimulations in culture, >90% of the cells expressed 
very high levels of CT antigen, and bound VV, HP, and Con A at high levels as 
well.  It  is  possible  that  IL-2  was  acting  on  a  second  non-CTL  in  the  MLC 
population, which was then inducing CTL to express high levels of CT antigen, 
or  that  IL-2  was  causing  the  expansion  of  a  small  percentage  of  cells  that 
expressed high  levels of CT  antigen.  We  feel  that  these  explanations  for CT 
antigen induction by I L-2 are not valid, since, early after activation in a primary 
MLC,  the  majority  of the  T200  molecules  have  undergone  modification  and 
40-60%  of the cells are CT  + (10).  That IL-2 can act directly on CTL to cause 
CT determinant expression is suggested by the finding that a cloned, cytolytically 
inducible T  cell hybridoma concomitantly expresses lytic activity, CT antigens, 
and marked changes in cell surface carbohydrate after induction by either Con 
A-stimulated  spleen cell supernatants,  which  contain  many soluble  factors,  or LEFRANCO1S  ET  AL.  1287 
rIL-2 (Lefrancois and Kanagawa, manuscript submitted for publication). Thus, 
IL-2 is able to act on a single cell type to induce the expression of carbohydrate 
differentiation antigens. 
Discussion 
The importance of carbohydrate structures in protein transport and secretion 
and as differentiation and tumor antigens has become evident of late (42).  A 
number of mAb specific for oligosaccharide moieties have recently been de- 
scribed that  define oncofetal antigens,  stage-specific embryonic antigens,  and 
antigens of neuronal cell subsets (42-44). Neural cell adhesion molecules, myelin- 
associated glycoprotein, and human NK cells appear to share a common carbo- 
hydrate antigen (45).  As yet, little is known of the function of these saccharide 
antigens. Our discovery of the presence of T  cell subset-specific carbohydrate 
antigens  further  indicates  an  important  role  for  carbohydrates  in  cell  type- 
specific differentiation. Furthermore, the CT antigens appear to be of functional 
significance, since CT-specific mAb inhibit CTL-mediated lysis (9).  Because CT 
mAb bind to a number of proteins at the CTL cell surface (T200, gp140, gp85), 
we have been unable as yet to determine if the functional inhibition of CTL is 
the result of CT mAb binding to one or more of these proteins. Alternatively, 
CT  mAb may react with glycolipids at the cell surface and inhibit lysis by an 
unknown mechanism. Quantitatively,  the  T200  glycoproteins bind  more CT 
than gpl40 or gp85, and other antibodies to T200 have been shown to inhibit 
NK- and CTL-induced lysis, although this latter point remains controversial. A 
functional role for T200 in ceil-mediated lysis has also been suggested by a study 
(46) which showed that T200 is a major cell surface protein that binds N-tosyl- 
L-lysyl-chloromethyl ketone (TLCK),  an  inhibitor  of trypsin-like proteases.  In 
addition, TLCK inhibits CTL-induced lysis (47). In support of this finding is the 
recent report (22) suggesting that the T200 glycoprotein may be an enzyme with 
Ca++-dependent autoproteolytic activity. The authors (22) discussed the similar- 
ities  of the  T200-associated  protease  and  the  protease  that  activates  protein 
kinase C (48) and is the endogenous enzyme that cleaves the epidermal growth 
factor (EGF) receptor (49).  Like the EGF receptor, the T200  molecule has an 
unusually large intracytoplasmic domain (Mr 80  K) with several possible phos- 
phorylation sites, although little sequence homology between T200 and the EGF 
receptor was noted (50).  Interestingly, carbohydrate structures related to blood 
group-specific oligosaccharides have been described on the leukocyte common 
antigen of human lymphocytes (51, 52) and the EGF receptor glycoprotein (53). 
Thus, it seems likely that T200  is important in transmembrane signaling, and 
carbohydrate structures found on the protein may be involved in this process. 
T200,  therefore,  seems a  probable  candidate  for  CT-mediated  inhibition  of 
CTL-directed lysis. 
In regard to the CT-reactive gpl40 found at the CTL cell surface, it may be 
noteworthy that other investigators have previously described a  Lyt-2  + T  cell- 
specific protein called T145  (54,  55).  T145  was isolated from T  cell blasts by 
fractionation  of cell  surface glycoproteins with  VV.  However,  the  functional 
significance of T 145 in the lytic mechanism has been questioned, since cytolytic 
T  cell populations selected on the basis of VV binding showed no difference in 1288  CYTOTOXIC  T  LYMPHOCYTE-SPECIFIC  CARBOHYDRATE  ANTIGENS 
the lytic ability of CTL expressing low or high levels of VV-reactive carbohydrate 
(56),  and  since  T145-  CTL  also  have  lytic capabilities  (57).  Our  preliminary 
studies indicate that the gp 140 described here and T 145 are similar. 
The exact carbohydrate specificity of the CT antibodies is at present unknown. 
However, recent  experiments  by Conzelmann  and  Kornfeld  (58,  59)  suggest 
interesting  possibilities.  Based  on  the  knowledge  that  CTL  lines  which  are 
independent of stimulator cells but dependent on I L-2 have high levels of binding 
sites for VV (60), these authors isolated glycopeptides for carbohydrate analysis 
from VV-sensitive or -resistant CTL lines. VV has been shown (60) to be highly 
cytotoxic for cell lines that express high levels of VV-reactive determinants.  The 
results indicate the presence on VV-binding CTL of O-linked oligosaccharides 
that contain  GalNAc linked in a ill,4 configuration to galactose at their nonre- 
ducing termini.  This configuration  was not detected on CTL that did not bind 
VV.  Furthermore,  a  VV-resistant  mutant  cell  line  was  deficient  in  the  N- 
acetylgalactosaminyltransferase apparently responsible for the addition of these 
residues.  Our  demonstration  that  CT  mAb,  VV, and  HP cell  surface binding 
was  influenced  greatly  by  the  functional  T  cell  phenotype  suggests  that  the 
particular  oligosaccharide moiety described by these authors may influence CT 
mAb reactivity. In fact, CT and VV have strikingly similar binding distributions 
(Fig.  7).  However, it is clear from comparisons of CT-reactive and VV-reactive 
molecules isolated from the CTL cell surface that VV has specificity for a much 
broader array of proteins than the CT mAb (Lefrancois and Kanagawa, submit- 
ted for publication). 
The  finding that  IL-2 influences CT determinant  expression (and other cell 
surface carbohydrate modifications;  Fig.  7) suggests for the first time that  this 
hormone-like  lymphokine  may regulate  glycosylation of specific proteins.  IL-2 
has been shown to be a proliferative signal for T  cells (61) as well as for B cells 
(62) and also influences CTL differentiation in the absence of proliferation (63, 
64).  The  mechanisms  leading  to these events after interaction  of IL-2 with  its 
membrane-bound  receptor  have  not  been  clearly  elucidated.  Although  1L-2 
induces proliferation  in both CTL and Th cells, the effects of IL-2 on glycosyl- 
ation that result in CT antigen expression occur in a cell type-specific manner. 
This could be accomplished by induction or regulation of a specific glycosyltrans- 
ferase (e.g., N-acetylgalactosaminyltransferase) or by affecting transcription and/ 
or translation  of proteins, thereby introducing new glycosylation sites. 
Our  results with  tunicamycin-treated  cells and  the results of the pulse chase 
experiments  indicated  the  presence  of at  least three  precursor  proteins  corre- 
sponding to the three major cell surface T200 proteins of cloned CTL. This is 
in contrast to earlier  results obtained with murine  thymocytes which showed a 
single T200 precursor protein of Mr  160 K (33).  Thus,  major alterations  seem 
to occur during activation of CTL. When CTL clones were grown in an antigen- 
independent  manner  with  very high  concentrations  of supernatants  from  Con 
A-stimulated  spleen  cells,  an  increase  in  the  molecular  weight  of the  T200 
protein was observed (65). Tung and coworkers (32) have also noted differences 
between functional  T  cell types and they observed two proteins of Mr 210 and 
215  K  at  the  cell  surface  of  Lyt-2  +  clones;  however,  no  studies  identifying 
precursors  to the surface forms were performed  (32).  Our preliminary  results LEFRANCOIS ET  AL.  1289 
indicate that Th cells also express different T200  precursor proteins than do 
CTL.  There  has  been  some  question  as  to  whether the  observed  molecular 
weight differences between the T200  forms of various T  cell types and the B 
cell  form  of T200  (B220;  66,  67)  are  due  to  actual  protein  differences or 
posttranslational modifications. The  recent  demonstration (50)  of mRNAs  of 
different sizes  coding for  the  leukocyte common  antigen  (i.e.,  T200)  of rat 
thymocytes  and B cells indicates differences at the protein level. Indeed, we have 
noted size  differences in the T200  mRNA of CTL and Th (M.  Thomas and 
Lefrancois, unpublished results). In our current investigations we hope to eluci- 
date the mechanisms allowing the expression of multiple T200  forms on func- 
tionally disparate T  cells and to examine the intriguing possibility that IL-2 may 
influence this discordant expression as well as posttranslational modifications of 
T200 and other glycoproteins. 
Summary 
Cytotoxic T  cell (CTL)-specific activation antigens, termed CT determinants, 
have been detected by monoclonal antibodies (mAb) that inhibit CTL function. 
At the cell surface, the CT antigens are associated with the T200 glycoproteins 
and two other proteins of Mr  140,000 and 85,000 and are present on a secreted 
protein, gp155.  Periodate treatment followed by binding analysis and immuno- 
precipitation experiments using tunicamycin-treated cells indicated that carbo- 
hydrate is necessary for CT antigen expression. Furthermore, gp155 is secreted 
in  the presence  of tunicamycin while retaining the  CT antigens, and the CT 
determinants are added late in T200 biosynthesis, suggesting that the CT glycans 
are  O-linked.  Finally, interleukin  2  was  shown  to  dramatically influence the 
expression of the CT  mAb-reactive oligosaccharides present at  the  CTL cell 
surface. 
We acknowledge  the expert assistance of Donald  N.  McQuitty  in the flow cytometry 
experiments. 
Received for publication  20June 1985. 
References 
1.  Meuer, S. C., K. A. Fitzgerald, R. E. Hussey, J. C. Hudgdon, S. F. Schlossman, and 
E.  L. Reinherz.  1983. Clonotypic structures  involved in antigen-specific human T 
cell function: relationship to the T3 molecular complex.]'. Exp. Med.  157:705. 
2.  Lancki, D. W., M. I. Lorber, M. R. Loken, and F. W. Fitch. 1982. A clone-specific 
monoclonal antibody that inhibits cytolysis of a cytolytic T  cell clone. J. Exp.  Med. 
157:921. 
3.  Chang,  T.  W.,  P.  C.  Kung,  S.  P.  Gingras,  and G.  Goldstein.  1981. Does OKT3 
monoclonal antibody react with an antigen-recognition  structure on human T cells? 
Proc. Natl. Acad.  Sei. USA. 78:I805. 
4.  Platsoucas, C. D., and R. A. Good. 1981. Inhibition of specific cell-mediated cytotox- 
icity by monoclonal antibodies to human T cell antigens. Proc. Natl. Acad.  Sci. USA. 
78:4500. 
5.  Nakayama, E., H. Shiku, E. Stockert, H. F. Oettgen, and L.J. Old.  1979. Cytotoxic 1290  CYTOTOXIC T  LYMPHOCYTE-SPECIFIC  CARBOHYDRATE  ANTIGENS 
T  ceils:  Lyt phenotype and blocking of killing activity by Lyt antisera. Proc.  Natl. 
Acad. Sci. USA.  76:1977. 
6.  Shinohara,  N.,  and  D.  H.  Sachs.  1979.  Mouse alloantibodies  capable of blocking 
cytotoxic T  cell function. I. Relationship between the antigen reactive with blocking 
antibodies and the Lyt-2 locus. J. Exp. Med.  150:432. 
7.  Dialynas, D.  P.,  Z.  S. Quan,  K. A.  Wall, A.  Pierres, J.  Quintans,  M.  R.  Loken,  M. 
Pierres,  and  F.  W.  Fitch.  1983.  Characterization  of the  murine  T  cell  surface 
molecule, designated  L3T4,  defined  by monoclonal antibody GK1.5:  similarity of 
L3T4 to the human Leu-3/T4 molecule. J. Immunol.  131:2445. 
8.  Martz,  E., and S.  H. Gromkowski.  1984.  Lymphocyte function-associated antigens: 
regulation of lymphocyte adhesions in vitro and immunity in vivo. Adv.  Exp.  Med. 
Biol. In press. 
9.  Lefrancois,  L.,  and  M. J.  Bevan.  1985.  Functional  modifications of cytotoxic T- 
lymphocyte T200 glycoprotein recognized by monoclonal antibodies. Nature (Lond.). 
314:449. 
10.  Lefrancois, L., and M.J.  Bevan.  1985b.  Novel antigenic determinants of the T200 
glycoprotein  expressed  preferentially  by activated  cytotoxic  T  cells. J.  Immunol. 
135:374. 
11.  Scheid,  M.  P., and D. Triglia.  1979.  Further description of the Ly-5 system. Immu- 
nogenetics.  9:423. 
12.  Kasai, M., J. C. Leclerc, F. W. Shen, and H. Cantor.  1979. Identification of Ly-5 on 
the  surface  of natural  killer  cells  in  normal  and  athymic  inbred  mouse  strains. 
Immunogenetics.  8:153. 
13.  Seaman, W. E., N. Talal, L. A. Herzenberg, L. A. Herzenberg, andJ. A. Ledbetter. 
1981. Surface antigens on mouse natural killer cells: use of monoclonal antibodies to 
inhibit or to enrich cytotoxic activity.J. Immunol.  127:982. 
14.  Omary, M.  B.,  I. S.  Trowbridge, and  M.  P.  Scheid.  1980.  The T200  cell surface 
glycoprotein of the mouse. Polymorphism defined by the Ly-5 system ofalloantigens. 
J. Exp. Med.  151:1311. 
15.  Siadak, A. W., and R. C. Nowinski.  1980. Identification of Ly-5 and T200 antigens 
on identical cell surface proteins. J. Immunol.  125:1400. 
16.  Harp, J.  A.,  B.  S.  Davis, and  S. J.  Ewald.  1984.  Inhibition of T  cell  responses to 
alloantigens and polyclonal mitogens by Ly-5 antisera.J. Immunol.  133:10. 
17.  Minato,  N.,  L.  Reid,  H.  Cantor,  P.  Lengyel,  and  B.  R.  Bloom.  1980.  Mode  of 
regulation of natural killer cell activity by interferon.J. Exp. Med.  152:124. 
18.  Brooks, C. G., K. Kuribayashi, G. E. Sole, and C. S. Henney. 1982. Characterization 
of five cloned murine cell lines showing high cytolytic activity against YAC-1  cells. J. 
Immunol.  128:2326. 
19.  Davignon,  D.,  E.  Martz,  T.  Reynolds,  T.  Kurzinger,  and  T.  A.  Springer.  1981. 
Lymphocyte function-associated antigen one (LFA-1): a surface antigen distinct from 
Lyt-2/3 that participates in T  lymphocyte-mediated killing. Proc. Natl. Acad. Sci. USA. 
78:4535. 
20.  Newman,  W.,  L.  D.  Fast,  and  L.  M.  Rose.  1983.  Blockade  of NK cell  lysis  is  a 
property of monoclonal antibodies that bind to distinct regions of T200. J. lmmunol. 
131:1742. 
21.  Yakura, H., F. W. Shen, E. Bourcet, and E. A. Boyse. 1983. On the function of Lyo 
5 in the regulation of antigen-driven B cell differentiation. J. Exp. Med.  157:1077. 
22.  Ewald, S. J., and P. H. Refling.  1985. Co-immunoprecipitation of the Ly-5 molecule 
and an endogenous protease: a  proteolytic system requiring a  reducing agent and 
CaZ+.J.  lmmunol.  134:2513. 
23.  Marshak-Rothstein, A., P.J.  Fink, T. Gridley, D. H. Raulet, M.J. Bevan, and M. L. LEFRANCOIS  ET  AL.  1291 
Gefter.  1979.  Properties and applications of monoclonal antibodies directed against 
determinants of the Thy- 1 locus. J. lmmunol.  122:2491. 
24.  Ledbetter, J. A., and L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to 
mouse lymphoid differentiation antigens, lmmunol. Rev. 47:64. 
25.  Trowbridge, I. S.  1978.  Interspecies spleen-myeloma hybrid producing monoclonal 
antibodies against the mouse lymphocyte surface glycoprotein, T200. J.  Exp.  Med. 
148:313. 
26.  Davidson, W.  F., and C.  R. Parish.  1975.  A  procedure for removing red cells  and 
dead cells from lymphoid cell suspensions. J. Immunol. Methods.  7:291. 
27.  Hubbard,  A.  L., and  Z.  A.  Cohn.  1972.  The enzymatic iodination of the red cell 
membrane.J. Cell. Biol. 55:390. 
28.  Kurnick, J.  T.,  L.  Ostberg,  M.  Stegagno, A.  K.  Kimura, A.  Orn, and O. Sjoberg. 
1979. A rapid method for the separation of functional lymphoid cell populations of 
human and animal origin on PVP-silica (Percoll) density gradients. Scand. J. lmmunol. 
10:563. 
29.  Laemmli,  U.  K.  1970.  Cleavage of structural  proteins during  the assembly of the 
head of bacteriophage T4. Nature (Lond.). 227:680. 
30.  Bonner, W. M., and R. A. Laskey. 1974. A film detection method for tritium-labeled 
proteins and nucleic acids in polyacrylamide gels. Eur. J. Biochem.  46:83. 
31.  Cleveland, D. W., S. G. Fischer, M. W. Kirschner, and U. K. Laemmli. 1977. Peptide 
mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electro- 
phoresis. J. Biol. Chem.  252:1102. 
32.  Tung, J. S.,  M.  C. Deere, and E. A. Boyse.  1984.  Evidence that Ly-5 product of T 
and B ceils differ in protein structure. Immunogenetics.  19:149. 
33.  Tung, J. S., M. P. Scheid, and M. A. Palladino.  1983. Different forms of Ly-5 within 
the T  cell lineage, lmmunogenetics.  17:649. 
34.  Spiro, R. G.  1966. Characterization of carbohydrate units of glycoproteins. Methods 
Enzymol.  8:26. 
35.  Olden, K., J. B. Parent, and S. L. White.  1982. Carbohydrate moieties of glycopro- 
reins. A reevaluation of their function. Biochim.  Biophys. Acta. 650:209. 
36.  Kaladas, P.  M., E. A. Kabat, A. Kimura, and B. Ersson.  1981. The specificity of the 
combining site of the  lectin from Vicia villosa  seeds which reacts with cytotoxic T- 
lymphoblasts. Mol. Immunol.  18:969. 
37.  Tollefsen, S. E., and R. Kornfeld. 1983. Isolation and characterization of lectins from 
Vicia villosa. Two distinct carbohydrate binding activities are present in seed extracts. 
J. Biol. Chem.  258:5165. 
38.  Carlin, B., R.Jaffe, B. Bender, and A. E. Chung.  1981. Entactin, a novel basal lamina 
associated sulfated glycoprotein. J. Biol.  Chem.  256:5209. 
39.  Hogan, B. L. M., A. Taylor, M. Kurkinen, andJ. R. Couchman.  1982. Synthesis and 
localization of two sulphated glycoproteins associated with basement membranes and 
the extracellular matrix.J. Cell. Biol. 95:197. 
40.  Tarentino,  A.  L.,  and  F.  Maley.  1974.  Purification  and  properties of an  endo-/3- 
acetylglucosaminidase from Streptomyces griseus. J. Biol. Chem.  249:811. 
41.  Hanover, J. A., and W.J.  Lennarz.  1981.  Transmembrane assembly of membrane 
and secretory glycoproteins. Arch. Biochem.  Biophys.  211:1. 
42.  Feizi, T. 1985. Demonstration by monoclonal antibodies that carbohydrate structures 
of glycoproteins and  glycolipids are  oncodevelopmental antigens.  Nature  (Lond.). 
314:53. 
43.  Dodd, J., D. Solter, and T. M. Jessell. 1984. Monoclonal antibodies against carbohy- 
drate  differentiation  antigens  identify subsets of primary sensory neurons.  Nature 
(Lond.). 311:469. 1292  CYTOTOXIC T  LYMPHOCYTE-SPECIFIC  CARBOHYDRATE  ANTIGENS 
44.  Shevinsky,  L.  H.,  B.  B.  Knowles,  I.  Damjanov, and  D.  Solter.  1982.  Monoclonal 
antibody to murine embryos defines a stage-specific embryonic antigen expressed on 
mouse embryos and human teratocarcinoma cells. Cell.  30:697. 
45.  Kruse, J., R. Mailhammer, H. Wernecke, A. Faissner, I. Sommer, C. Goridis, and M. 
Schachner.  1984. Neural cell adhesion molecules and myelin-associated glycoprotein 
share a common carbohydrate moiety recognized by monoclonal antibodies L2 and 
HNK-1. Nature (Lond.).  311:153. 
46.  Pasternack, M. S.,  M. V. Sitkovsky, and H. N. Eisen.  1983. The site of action of N- 
a-tosyl-L-lysyl  chlorometbyl ketone (TLCK) on cloned cytotoxic T  lymphocytes. J. 
Immunol.  131:2477. 
47.  Chang, T. W., and H. N. Eisen. 1980. Effects ofN-a-tosyl-L-lysyl  chloromethyl ketone 
on the activity of cytotoxic T  lymphocytes.J, lmmunol.  124:1028. 
48.  Kishimoto, A., N. Najikawa, M. Shiota, and Y. Nishizuka. 1983. Proteolytic activation 
of calcium-activated, phospholipid-dependent  protein  kinase by calcium-dependent 
neutral protease. J. Biol.  Chem.  258: I 156. 
49.  Gates, R. E., and L. E. King. 1982. Calcium facilitates endogenous proteolysis of the 
EGF receptor-kinase. Mol.  Cell.  Endocr.  27:263. 
50.  Thomas, M. L., A. N. Barclay, J. Gagnon, and A. F. Williams.  1985. Evidence from 
cDNA clones that the rat leucocyte-common antigen (T200) spans the lipid bilayer 
and contains a cytoplasmic domain of 80,000 Mr. Cell.  41:83. 
51.  Childs,  R.  A.,  and  T.  Feizi.  1981.  Differences  in  carbohydrate  moieties of high 
molecular weight glycoproteins of human lymphocytes of T  and B origins revealed 
by monoclonal autoantibodies with anti-I and anti-i specificities. Biochem.  Biophys.  Res. 
Commun.  102:1158. 
52.  Childs,  R.  A.,  R.  Dolchau,  P.  Scudder,  E.  F.  Hounsell, J.  W.  Fabre,  and T.  Feizi. 
1983. Evidence for the occurrence of O-glycosidically linked oligosaccharides of poly- 
n-acetyllactosamine type on the human leucocyte common antigen. Biochem.  Biophys. 
Res. Commun.  110:424. 
53.  Childs,  R.  A.,  R.  Gregoriou,  P.  Scudder,  S.J.  Thorpe, A.  R.  Rees, and  T.  Feizi. 
1984. Blood group-active carbohydrate chains on the receptor for epidermal growth 
factor of A431 cells. EMBO (Eur. Mol. Biol. Org.)J.  3:2227. 
54.  Kimura, A. K., and H. Wigzell. 1978. Cell surface glycoproteins of murine cytotoxic 
T  lymphocytes. I. T145, a new cell surface glycoprotein selectively expressed on Ly- 
1-2 + cytotoxic T  lympbocytes.J. Exp. Med.  147:1418. 
55.  Kimura, A.,  H. Wigzell, G. Holmquist, B. Ersson, and P.  Carlsson.  1979.  Selective 
affinity  fractionation  of  murine  cytotoxic  T  lymphocytes  (CTL).  Unique  lectin- 
specific binding  of the  CTL-associated  surface  glycoprotein,  T145. J.  Exp.  Med. 
149:473. 
56.  MacDonald,  H.  R., J.  P.  Mach,  M.  Schreyer,  P.  Zaech, and J.  C.  Cerottini.  1981. 
Flow cytofluorometric analysis of the binding of Vicia villosa lectin to T  lymphoblasts: 
lack of correlation with cytolytic function. J. Immunol.  126:883. 
57.  Kaufmann,  Y.,  and  G.  Berke.  1981.  Cell  surface  glycoproteins  of  cytotoxic  T 
lymphocytes induced in vivo and in vitro.J. Immunol.  126:1443. 
58.  Conzelmann,  A.,  and S.  Kornfeld.  1984a.  /3-1inked N-acetylgalactosamine residues 
present at the nonreducing termini of O-linked oligosaccharides of a cloned murine 
cytotoxic T  lymphocyte line are absent in a  Vicia  villosa lectin-resistant mutant cell 
line. J. Biol.  Chem. 259:12528. 
59.  Conzelmann, A., and S. Kornfeld.  1984. A murine cytotoxic T  lymphocyte cell line 
resistant  to  Vicia  villosa  lectin  is  deficient  in  UDP-GalNAc:  j3-Galactose  /31,4-n- 
acetylgalactosaminyltransferase. J. Biol. Chem.  259:12536. 
60.  Conzelmann, A., R. Pink, O. Acuto, J. P.  Prach, S. Dolivo, and M.  Nabholz.  1980. LEFRANCOIS ET  AL.  1293 
Presence of T 145 on cytolytic T  cell lines and their lectin-resistant mutants. Eur. J. 
Immunol.  10:860. 
61.  Robb,  R. J.,  A.  Munck, and  K.  A.  Smith.  1981.  T  cell  growth  factor receptors. 
Quantitation, specificity,  and biological relevance. J. Exp. Med.  154:1455. 
62.  Zubler,  R.  H., J.  W.  Lowenthal,  F.  Erand,  N.  Hashimoto,  R.  Devas,  and  H.  R. 
MacDonald. 1984. Activated B cells express receptors for, and proliferate in response 
to, pure interleukin 2.J. Exp. Med.  160:1170. 
63.  Ryser, J.  E., J.  C.  Cerottini,  and  K.  T.  Brunner.  1978.  Generation of cytolytic T 
lymphocytes in  vitro.  IX. Induction of secondary CTL responses in  primary long- 
term MLC by supernatants from secondary MLC. J. Immunol.  120:370. 
64.  Lefrancois, L., J. R. Klein, V. Paetkau, and M.J. Bevan.  1984. Antigen-independent 
activation of memory cytotoxic T  cells by interleukin 2. J. Immunol.  137:1845. 
65.  Brooks, C. G.,  D. L. Urdal, and C. S. Henney.  1983. Lymphokine-driven "differen- 
tiation" of cytotoxic T-cell clones into cells with NK-like specificity:  correlations with 
display of membrane molecules, lmmunol.  Rev.  72:43. 
66.  Trowbridge,  I.  S.,  P.  Ralph,  and  M. J.  Bevan.  1975.  Differences  in  the  surface 
proteins of mouse B and T  cells. Proc. Natl. Acad. Sci.  USA.  72:157. 
67.  Coffman, R.  L., and I. L.  Weissman.  1981.  B220: A B cell-specific  member of the 
T200 glycoprotein family. Nature (Lond.).  289:681. 